Oblique Therapeutics

Biotechnology, Health Care, Hospital, Medical, Pharmaceutical
Founded in 2015-01-01
Göteborg, Vastra Gotaland, Sweden
For Profit

About Oblique Therapeutics

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 2500000 USD
  • Last Funding: 2500000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Oblique Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Hospital, Medical, Pharmaceutical

Headquarters: Göteborg, Vastra Gotaland, Sweden